Management of seasonal allergic conjuctivitis (SAC): current therapeutic strategies

被引:13
作者
Anderson, DF [1 ]
机构
[1] Univ Southampton, Eye Unit, Southampton S016 6YD, Hants, England
关键词
D O I
10.1046/j.1365-2222.2001.01148.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:823 / 826
页数:4
相关论文
共 34 条
  • [1] ABELSON MB, 1981, ARCH OPHTHALMOL-CHIC, V99, P302
  • [2] Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration
    Anderson, DF
    MacLeod, JDA
    Baddeley, SM
    Bacon, AS
    McGill, JI
    Holgate, ST
    Roche, WR
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (09) : 1060 - 1066
  • [3] Anderson DF, 2001, INVEST OPHTH VIS SCI, V42, P995
  • [4] Bacon AS, 1998, INVEST OPHTH VIS SCI, V39, P322
  • [5] CLINICAL-EVALUATION OF KETOROLAC TROMETHAMINE 0.5-PERCENT OPHTHALMIC SOLUTION FOR THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS
    BALLAS, Z
    BLUMENTHAL, M
    TINKELMAN, DG
    KRIZ, R
    RUPP, G
    [J]. SURVEY OF OPHTHALMOLOGY, 1993, 38 : 141 - 148
  • [6] FAILURE OF PUTATIVE IGE PENTAPEPTIDE TO COMPETE WITH IGE FOR RECEPTORS ON BASOPHILS AND MAST-CELLS
    BENNICH, H
    RAGNARSSON, U
    JOHANSSON, SGO
    ISHIZAKA, K
    ISHIZAKA, T
    LEVY, DA
    LICHTENSTEIN, LM
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1977, 53 (05): : 459 - 468
  • [7] Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis
    Bonini, S
    Schiavone, M
    Bonini, S
    Magrini, L
    Lischetti, P
    Lambiase, A
    Bucci, MG
    [J]. OPHTHALMOLOGY, 1997, 104 (05) : 849 - 853
  • [8] INTERLEUKIN-4 IS LOCALIZED TO AND RELEASED BY HUMAN MAST-CELLS
    BRADDING, P
    FEATHER, IH
    HOWARTH, PH
    MUELLER, R
    ROBERTS, JA
    BRITTEN, K
    BEWS, JPA
    HUNT, TC
    OKAYAMA, Y
    HEUSSER, CH
    BULLOCK, GR
    CHURCH, MK
    HOLGATE, ST
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1381 - 1386
  • [9] NEDOCROMIL SODIUM - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ASTHMA
    BROGDEN, RN
    SORKIN, EM
    [J]. DRUGS, 1993, 45 (05) : 693 - 715
  • [10] Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro
    Buscaglia, S
    Paolieri, F
    Catrullo, A
    Fiorino, N
    Riccio, AM
    Pesce, G
    Montagna, P
    Bagnasco, M
    Ciprandi, G
    Canonica, GW
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 (10) : 1188 - 1196